(Total Views: 248)
Posted On: 04/12/2022 12:41:20 PM
Post# of 1418
New Study Reportedly Calls Into Question Merck's Ivermectin COVID Off Label Use And May Bolster 3CL Protease Inhibitors Such As Tollovid - April 12, 2022 8:23 AM
https://www.benzinga.com/general/biotech/22/0...bolster-3c
https://www.benzinga.com/general/biotech/22/0...bolster-3c
(1)
(0)